PHASE-I TRIAL OF HIGH-DOSE ARA-C (18 GM M(2)/D) ADMINISTERED AS A 96-HOUR CONTINUOUS-INFUSION IN CONJUNCTION WITH DE-ESCALATING DOSES OF 2'-DEOXYCYTIDINE (IND-28108) IN PATIENTS WITH REFRACTORY HEMATOLOGIC MALIGNANCIES/

Authors
GRANT S ROBERTS J TOMBES MB KYLE B
Citation
S. Grant et al., PHASE-I TRIAL OF HIGH-DOSE ARA-C (18 GM M(2)/D) ADMINISTERED AS A 96-HOUR CONTINUOUS-INFUSION IN CONJUNCTION WITH DE-ESCALATING DOSES OF 2'-DEOXYCYTIDINE (IND-28108) IN PATIENTS WITH REFRACTORY HEMATOLOGIC MALIGNANCIES/, Blood, 90(10), 1997, pp. 3827-3827
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
90
Issue
10
Year of publication
1997
Part
2
Supplement
1
Pages
3827 - 3827
Database
ISI
SICI code
0006-4971(1997)90:10<3827:PTOHA(>2.0.ZU;2-P